Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Repeated Dosing of Psilocybin on Obsessive-Compulsive Disorder: A Randomized, Waitlist-Controlled Study

NCT05370911 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT05370911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05370911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Repeated Dosing of Psilocybin on Obsessive-Compulsive Disorder: A Randomized, Waitlist-Controlled Study
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 20, 2023
Completion date
February 28, 2027
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive-compulsive disorder